[Neovascularization and tumor development].
Ono
M
M
Kuwano
M
M
D043168:Angiostatins; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003094:Collagen / Q000627:therapeutic use; D003510:Cyclohexanes; D043169:Endostatins; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D018664:Interleukin-12 / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy / Q000473:pathology*; D009389:Neovascularization, Pathologic; D000077609:O-(Chloroacetylcarbamoyl)fumagillol; D010446:Peptide Fragments / Q000627:therapeutic use; D010649:Phenylalanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D010958:Plasminogen / Q000627:therapeutic use; D012717:Sesquiterpenes / Q000627:therapeutic use; D013792:Thalidomide / Q000627:therapeutic use; D013876:Thiophenes / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D003510:Cyclohexanes; D043169:Endostatins; D006877:Hydroxamic Acids; D010446:Peptide Fragments; D012717:Sesquiterpenes; D013876:Thiophenes; D018664:Interleukin-12; D010649:Phenylalanine; D013792:Thalidomide; D043168:Angiostatins; D010958:Plasminogen; D003094:Collagen; D007372:Interferons; C080985:batimastat; C100342:marimastat; D000077609:O-(Chloroacetylcarbamoyl)fumagillol